Organogenesis Holdings (ORGO) just unveiled an announcement.
At the company’s Annual Meeting, stockholders decisively passed four proposals, including the election of eleven directors to serve until the next meeting, the approval of executive compensation on an advisory basis, an amendment to increase the number of shares for the Equity Incentive Plan, and the ratification of RSM US LLP as the independent auditor for the fiscal year. The strong shareholder participation and affirmative votes reflect confidence in the company’s governance and strategic incentives.
See more insights into ORGO stock on TipRanks’ Stock Analysis page.
